Argenica Therapeutics Ltd (AU:AGN) has released an update.
Arigenica Therapeutics Limited has announced the application for quotation of 23,076,924 ordinary fully paid securities under the ASX security code AGN, with the issue date slated for April 22, 2024. This move indicates the company’s intention to expand its presence on the Australian Securities Exchange, potentially signaling a growth phase for the biotech firm.
For further insights into AU:AGN stock, check out TipRanks’ Stock Analysis page.
